Literature DB >> 2886597

A comparative study of the interaction of warfarin with human alpha 1-acid glycoprotein and human albumin.

M Otagiri, T Maruyama, T Imai, A Suenaga, Y Imamura.   

Abstract

The interaction of warfarin with human alpha 1-acid glycoprotein (alpha 1-AGP) and human albumin (HA) has been investigated using fluorescence and circular dichroism techniques. The fluorescence of warfarin is greatly enhanced following binding to alpha 1-AGP or HA, the binding constant for a single site being estimated by the Scatchard method. The binding constants for the two serum proteins are similar, but the thermodynamic parameters differ. The binding constants increase as the pH is raised to 9.0. Various basic drugs, such as chlorpromazine, propranolol and imipramine, markedly inhibited the binding of warfarin to alpha 1-AGP. But, some acidic drugs, including phenylbutazone, effectively displaced warfarin bound to HA. The difference in CD spectra observed for alpha 1-AGP and HA indicated that the drug-binding sites of the two proteins might have different asymmetries. It thus appears that the mode of interaction of warfarin with the two proteins differs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886597     DOI: 10.1111/j.2042-7158.1987.tb03412.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

Review 1.  Pharmacogenetics of warfarin: challenges and opportunities.

Authors:  Ming Ta Michael Lee; Teri E Klein
Journal:  J Hum Genet       Date:  2013-05-09       Impact factor: 3.172

Review 2.  Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.

Authors:  Wen-ying Shu; Jia-li Li; Xue-ding Wang; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2015-04-20       Impact factor: 6.150

3.  Drug binding to alpha 1-acid glycoprotein studied by circular dichroism.

Authors:  M Otagiri; R Yamamichi; T Maruyama; T Imai; A Suenaga; Y Imamura; K Kimachi
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

4.  Five recombinant fragments of human serum albumin-tools for the characterization of the warfarin binding site.

Authors:  M Dockal; M Chang; D C Carter; F Rüker
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

Review 5.  Warfarin Pharmacogenetics: New Life for an Old Drug.

Authors:  Ming-Shien Wen; Ming Ta Michael Lee
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672

6.  Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.

Authors:  X Xu; P Selick; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1993-02

7.  Association of warfarin dose with genes involved in its action and metabolism.

Authors:  Mia Wadelius; Leslie Y Chen; Niclas Eriksson; Suzannah Bumpstead; Jilur Ghori; Claes Wadelius; David Bentley; Ralph McGinnis; Panos Deloukas
Journal:  Hum Genet       Date:  2006-10-18       Impact factor: 4.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.